about
Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation.Surgical biology for the clinician: vascular effects of immunosuppressionMycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection.Cellular effects of everolimus and sirolimus on podocytes.Myocardial infarction in an adult with cystic fibrosis and heart and lung transplant.Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targetsMetabolic syndrome in patients with hematological diseases.Effect of confounding factors on a phospho-flow assay of ribosomal S6 protein for therapeutic drug monitoring of the mTOR-inhibitor everolimus in heart transplanted patients.The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial.Comparison of MMF with prednisone in terms of rejection and duration of activity of transplant in rabbits that underwent retroperitoneal heterotopic heart transplantation.Efficacy and safety of low-dose everolimus as maintenance immunosuppression in cardiac transplant recipients.Outcomes after heart transplantation in patients with and without pretransplant renal dysfunction.Renal protection strategies after heart transplantation.
P2860
Q33391739-73B25964-8263-44CE-BBFD-9275237B0535Q33604754-A602F694-68AE-4EC3-B35A-561D9E59607CQ34607590-512205D8-772F-4418-BA57-44905A8D7099Q35048950-35F5FACD-4594-47FF-AB97-304B076234D6Q36921738-B04BB5C5-4228-4A85-A811-BD5C4E2FC130Q36993722-58992A2B-3B2A-43AF-A815-19402DBF7CC0Q38044776-1CAEC78F-D9D2-4C01-86CC-3C27A3AD448DQ39570274-4F7CA4F4-A876-4F50-976E-B43989068C8BQ41418523-DFE29CC1-95B1-46BC-B5EA-C90D8471778CQ41847223-CEEF2091-B867-480C-B1DF-915711DBC473Q41977248-E33466AF-796E-4582-91D4-8F75229D7881Q42009158-EFB27A0A-25D4-4ECC-9926-CDF505C167A1Q44779317-FD094149-4581-4B59-8993-763C0891BA4BQ48277261-1F3F8331-0BE7-4C2C-81F3-F65EE58B1CD4
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Calcineurin inhibitors in heart transplantation.
@ast
Calcineurin inhibitors in heart transplantation.
@en
type
label
Calcineurin inhibitors in heart transplantation.
@ast
Calcineurin inhibitors in heart transplantation.
@en
prefLabel
Calcineurin inhibitors in heart transplantation.
@ast
Calcineurin inhibitors in heart transplantation.
@en
P1476
Calcineurin inhibitors in heart transplantation.
@en
P2093
Anne Keogh
P304
P356
10.1016/J.HEALUN.2004.03.008
P433
P577
2004-05-01T00:00:00Z